Plain-English translation of NCT05222529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether glycopyrronium bromide, a new inhaled medication, is safe and effective for children ages 6 to 12 with asthma. During the study, children will try the medication at two different doses and a placebo (dummy treatment) while continuing their regular asthma controller medicine. Researchers want to learn how well the medication works, how the body processes it, and whether it causes any side effects.
Many children with asthma still have trouble controlling their symptoms even while taking standard asthma medications. This trial is exploring whether this new treatment could help provide better breathing control for kids who need additional help managing their asthma.
You likely qualify if…
You likely don't qualify if…
Over about 5 months total, you would visit the clinic for screening, then enter a 10-week treatment phase where you try the medication and placebo in different orders—each for 2 weeks with 2-week breaks between them—while keeping your regular asthma medicine. You would use a special inhaler device called a Breezhaler to take the study treatment, complete breathing tests at each visit, and your parent or guardian would track your symptoms in an electronic diary. At the end, you'll have a final phone check-in about a month after your last dose to make sure everything is okay.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Bulgaria
Colombia
Guatemala